Delivery Order SPE2DB24D2205-SPE2DB25FDSTT

Award Date 10/16/24
Potential Completion Date 11/6/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,779.12 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,793.03 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 29, 2024, with an ultimate completion date of September 20, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,168.02 firm fixed-price contract has an ultimate completion date of November 19, 2024 and was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 3, 2024, with a ceiling value of $5,779.12 and a completion date of December 24, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $16,758.18 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, on October 8, 2024. The contract has an ultimate completion date of October 30, 2024 and is not set aside for any special business category. Amerisourcebergen has a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,586.06 Firm Fixed Price Delivery Order is for BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 8, 2024 and was awarded on October 18, 2024. This award is a delivery order under AmerisourceBergen's larger $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,586.06 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with no set-aside designation. The award is a task order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which serves as the primary vehicle for AmerisourceBergen to...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication, to the Defense Logistics Agency (DLA). The $5,402.70 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 16, 2023 and was awarded on September 22, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of BENLYSTA 400 mg vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024, with a ceiling value of $7,557.00 and a completion date of November 19, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024, with a ceiling value of $5,779.12 and a completion date of January 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDSTT
    Delivery Order

This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,379.09 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024 with a completion date of November 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order does not have a set-aside designation, indicating open competition.

Generated 1/15/25, 9:33 AM